The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity
about
HIV type 1 Gag as a target for antiviral therapyVirus maturation as a new HIV-1 therapeutic targetNucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteinsCryo-electron microscopy of tubular arrays of HIV-1 Gag resolves structures essential for immature virus assemblyDrug-class specific impact of antivirals on the reproductive capacity of HIVStructural and functional insights into the HIV-1 maturation inhibitor binding pocketRole of the SP2 domain and its proteolytic cleavage in HIV-1 structural maturation and infectivityStructure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396Crystal structure of an HIV assembly and maturation switch.Design of in vitro symmetric complexes and analysis by hybrid methods reveal mechanisms of HIV capsid assemblyThe structural biology of HIV assembly.Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assayElectron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells.Differential pH-dependent cellular uptake pathways among foamy viruses elucidated using dual-colored fluorescent particlesThe nucleocapsid domain of Gag is dispensable for actin incorporation into HIV-1 and for association of viral budding sites with cortical F-actin.Helical structure determined by NMR of the HIV-1 (345-392)Gag sequence, surrounding p2: implications for particle assembly and RNA packagingHow HIV-1 Gag assembles in cells: Putting together pieces of the puzzle.Effect of dimerizing domains and basic residues on in vitro and in vivo assembly of Mason-Pfizer monkey virus and human immunodeficiency virus.Novel approaches to inhibiting HIV-1 replication.Identification of retroviral late domains as determinants of particle size.The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation.Structural analysis of HIV-1 maturation using cryo-electron tomography.Genetic determinants of Rous sarcoma virus particle size.Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain.A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assemblyParticle size determinants in the human immunodeficiency virus type 1 Gag proteinDetection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17.The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly.Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation.Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly.Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.Isolation of human immunodeficiency virus type 1 cores: retention of Vpr in the absence of p6(gag).Human immunodeficiency virus type 1 virion density is not determined by nucleocapsid basic residuesMutations within four distinct gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site.Alteration of zinc-binding residues of simian immunodeficiency virus p8(NC) results in subtle differences in gag processing and virion maturation associated with degradative loss of mutant NC.Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.Proper processing of avian sarcoma/leukosis virus capsid proteins is required for infectivitySecond-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactionsMultimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains
P2860
Q24614498-C90B3271-443B-409A-8AD8-DEB4FCDB96A4Q24642446-9169039C-FCF9-4F7A-98C0-BC441EE0047BQ25257759-2BA6AE03-E659-4D80-9989-64D8C5F2FCFBQ27683857-0765F4D3-137C-43F7-9094-3D1BDAE2C916Q28473451-3F9CF2CA-9A5D-4814-8F39-29570CA92BB7Q28485054-A2718A0B-C582-4299-A628-65BD9371D853Q28710568-938C664C-E7AE-45F8-BCC3-81932571198CQ28828191-156F13A9-227E-43A2-93A0-A9F0EA1D5160Q30276365-C9DA27E3-2632-4A16-A3E5-420C4537D3FCQ30425900-4716798E-3A6B-40B9-93EE-E86FB564AF84Q30437103-A81ECFD3-5A72-4455-81B7-F34192664E57Q30447057-A54F4F14-B0C2-434F-A2C0-65F433428687Q30479297-CC2C73A8-38AB-4051-B449-055239AAD6B4Q30528266-56428BC8-9220-4324-8A09-6F48D3FC4CFDQ30583700-C85919D6-00FF-4CEB-85D7-60FB41C43C73Q30980940-4C6843B1-4951-4BC5-B20E-DD73468959C1Q33358839-C3818AC2-BB44-458F-BFF3-AC16114AA62DQ33614514-F8362F1F-F599-4366-9579-8E922B332194Q33624690-118FC07E-4FB1-4C45-B1C4-196F2632073FQ33653548-06C38FE1-BC09-4F8E-BEB6-0BCFE3E9AE1BQ33727091-8B806B50-5014-4A49-BE35-9D7F71CEA79EQ33769181-C1099B82-3EAA-4833-8C2D-4A2684DFECB3Q33782075-2047A7E6-B07F-4B10-AF8E-9E5DFF3E9F28Q33782263-7D392EE8-D9D6-4EB4-97B4-F9FFB5FB7BA3Q33782377-4BD330B5-E3C8-4E6D-808D-5AFA311ADBDBQ33783955-CF2AADB0-9E97-485A-AD29-E7300D7604BAQ33784101-2B7E4194-2A83-457D-AA61-7A79D0C72524Q33785479-3F23416B-BA58-4AE8-9BCE-FE4546CF1468Q33785662-063FD18B-1913-4038-8F08-B5A030CDD8C5Q33787084-40F6E7F3-628D-41B6-A840-5CA8D8C6FA9FQ33794223-443EE73D-6BC8-4256-B652-A6532417FACFQ33805303-18F964A2-5410-47BB-8D7E-AA02AC316FB8Q33807166-F2E2068F-D889-4C8B-AFC9-6E00F61A27E1Q33808429-20189131-52E7-4746-8687-BF7F942CDD50Q33818125-0E4F0613-B215-4023-9E29-778CBA64D1E0Q33834585-C0608174-C911-4B07-86B5-95343885B940Q33841920-980DB018-AE86-49DA-BE18-F967B2456FBEQ33842469-323F192E-ED68-4E15-88DF-75456484851CQ33844210-73A4A172-9288-4253-BDE5-ABB78996E4FBQ33853532-E4AE957C-C6E8-4147-AF8B-E699901C44F1
P2860
The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
The spacer peptide between hum ...... assembly and viral infectivity
@en
The spacer peptide between hum ...... ssembly and viral infectivity.
@nl
type
label
The spacer peptide between hum ...... assembly and viral infectivity
@en
The spacer peptide between hum ...... ssembly and viral infectivity.
@nl
prefLabel
The spacer peptide between hum ...... assembly and viral infectivity
@en
The spacer peptide between hum ...... ssembly and viral infectivity.
@nl
P2093
P2860
P1433
P1476
The spacer peptide between hum ...... assembly and viral infectivity
@en
P2093
Kräusslich HG
Zentgraf H
P2860
P304
P407
P577
1995-06-01T00:00:00Z